Cargando…
Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States
SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614874/ https://www.ncbi.nlm.nih.gov/pubmed/34827190 http://dx.doi.org/10.3390/biology10111197 |
_version_ | 1784603966850465792 |
---|---|
author | Bulyáki, Éva Kun, Judit Molnár, Tamás Papp, Alexandra Micsonai, András Vadászi, Henrietta Márialigeti, Borbála Kovács, Attila István Gellén, Gabriella Yamaguchi, Keiichi Lin, Yuxi So, Masatomo Józsi, Mihály Schlosser, Gitta Lee, Young-Ho Liliom, Károly Goto, Yuji Kardos, József |
author_facet | Bulyáki, Éva Kun, Judit Molnár, Tamás Papp, Alexandra Micsonai, András Vadászi, Henrietta Márialigeti, Borbála Kovács, Attila István Gellén, Gabriella Yamaguchi, Keiichi Lin, Yuxi So, Masatomo Józsi, Mihály Schlosser, Gitta Lee, Young-Ho Liliom, Károly Goto, Yuji Kardos, József |
author_sort | Bulyáki, Éva |
collection | PubMed |
description | SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m mutant exhibiting normal serum levels and a distinct, visceral deposition pattern. D76N β2m showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Despite the extensive research, the molecular bases of the aberrant aggregation of β2m in vivo remains elusive. Here, using a variety of biophysical techniques, we investigated the role of the pathogenic D76N mutation in the amyloid formation of β2m by point mutations affecting the stabilizing ion-pairs of β2m. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular matrix proteins. Understanding the underlying molecular mechanisms might help to find target points for effective treatments against diseases associated with the deleterious aggregation of proteins. ABSTRACT: β(2)-microglobulin (β2m), the light chain of the MHC-I complex, is associated with dialysis-related amyloidosis (DRA). Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m variant, which showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Here, we investigated the role of the D76N mutation in the amyloid formation of β2m by point mutations affecting the Asp76-Lys41 ion-pair of WT β2m and the charge cluster on Asp38. Using a variety of biophysical techniques, we investigated the conformational stability and partial unfolding of the native state of the variants, as well as their amyloidogenic propensity and the stability of amyloid fibrils under various conditions. Furthermore, we studied the intermolecular interactions of WT and mutant proteins with various binding partners that might have in vivo relevance. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the deleterious synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules (e.g., lipids) and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular components, including extracellular matrix proteins. |
format | Online Article Text |
id | pubmed-8614874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86148742021-11-26 Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States Bulyáki, Éva Kun, Judit Molnár, Tamás Papp, Alexandra Micsonai, András Vadászi, Henrietta Márialigeti, Borbála Kovács, Attila István Gellén, Gabriella Yamaguchi, Keiichi Lin, Yuxi So, Masatomo Józsi, Mihály Schlosser, Gitta Lee, Young-Ho Liliom, Károly Goto, Yuji Kardos, József Biology (Basel) Article SIMPLE SUMMARY: Elevated β(2)-microglobulin (β2m) serum levels cause serious complications in patients on long-term kidney dialysis by depositing in the form of amyloid fibrils in the osteoarticular system. Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m mutant exhibiting normal serum levels and a distinct, visceral deposition pattern. D76N β2m showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Despite the extensive research, the molecular bases of the aberrant aggregation of β2m in vivo remains elusive. Here, using a variety of biophysical techniques, we investigated the role of the pathogenic D76N mutation in the amyloid formation of β2m by point mutations affecting the stabilizing ion-pairs of β2m. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular matrix proteins. Understanding the underlying molecular mechanisms might help to find target points for effective treatments against diseases associated with the deleterious aggregation of proteins. ABSTRACT: β(2)-microglobulin (β2m), the light chain of the MHC-I complex, is associated with dialysis-related amyloidosis (DRA). Recently, a hereditary systemic amyloidosis was discovered, caused by a naturally occurring D76N β2m variant, which showed a structure remarkably similar to the wild-type (WT) protein, albeit with decreased thermodynamic stability and increased amyloidogenicity. Here, we investigated the role of the D76N mutation in the amyloid formation of β2m by point mutations affecting the Asp76-Lys41 ion-pair of WT β2m and the charge cluster on Asp38. Using a variety of biophysical techniques, we investigated the conformational stability and partial unfolding of the native state of the variants, as well as their amyloidogenic propensity and the stability of amyloid fibrils under various conditions. Furthermore, we studied the intermolecular interactions of WT and mutant proteins with various binding partners that might have in vivo relevance. We found that, relative to WT β2m, the exceptional amyloidogenicity of the pathogenic D76N β2m variant is realized by the deleterious synergy of diverse effects of destabilized native structure, higher sensitivity to negatively charged amphiphilic molecules (e.g., lipids) and polyphosphate, more effective fibril nucleation, higher conformational stability of fibrils, and elevated affinity for extracellular components, including extracellular matrix proteins. MDPI 2021-11-17 /pmc/articles/PMC8614874/ /pubmed/34827190 http://dx.doi.org/10.3390/biology10111197 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bulyáki, Éva Kun, Judit Molnár, Tamás Papp, Alexandra Micsonai, András Vadászi, Henrietta Márialigeti, Borbála Kovács, Attila István Gellén, Gabriella Yamaguchi, Keiichi Lin, Yuxi So, Masatomo Józsi, Mihály Schlosser, Gitta Lee, Young-Ho Liliom, Károly Goto, Yuji Kardos, József Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title | Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title_full | Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title_fullStr | Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title_full_unstemmed | Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title_short | Pathogenic D76N Variant of β(2)-Microglobulin: Synergy of Diverse Effects in Both the Native and Amyloid States |
title_sort | pathogenic d76n variant of β(2)-microglobulin: synergy of diverse effects in both the native and amyloid states |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614874/ https://www.ncbi.nlm.nih.gov/pubmed/34827190 http://dx.doi.org/10.3390/biology10111197 |
work_keys_str_mv | AT bulyakieva pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT kunjudit pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT molnartamas pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT pappalexandra pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT micsonaiandras pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT vadaszihenrietta pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT marialigetiborbala pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT kovacsattilaistvan pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT gellengabriella pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT yamaguchikeiichi pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT linyuxi pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT somasatomo pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT jozsimihaly pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT schlossergitta pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT leeyoungho pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT liliomkaroly pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT gotoyuji pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates AT kardosjozsef pathogenicd76nvariantofb2microglobulinsynergyofdiverseeffectsinboththenativeandamyloidstates |